These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 6072765)

  • 1. Relationship between the long-acting thyroid stimulator and circulating thyroid antibodies in Graves' disease.
    Pinchera A; Liberti P; De Santis R; Grasso L; Martino E; Baschieri L
    J Clin Endocrinol Metab; 1967 Dec; 27(12):1758-60. PubMed ID: 6072765
    [No Abstract]   [Full Text] [Related]  

  • 2. Measurements by competitive binding radioassay of serum anti-microsomal and anti-thyroglobulin antibodies in Graves' disease and other thyroid disorders.
    Mori T; Kriss JP
    J Clin Endocrinol Metab; 1971 Oct; 33(4):688-98. PubMed ID: 5109861
    [No Abstract]   [Full Text] [Related]  

  • 3. Thyroidal effects of injections of Graves' disease thyroid microsomes in rhesus monkeys.
    Furth ED; Dentinger M
    Endocrinology; 1971 Jul; 89(1):310-5. PubMed ID: 4103749
    [No Abstract]   [Full Text] [Related]  

  • 4. A reconsideration of a thyroid-stimulating immunoglobulin as the cause of hyperthyroidism in Graves' disease.
    McKenzie JM; Zakarija M
    J Clin Endocrinol Metab; 1976 Apr; 42(4):778-81. PubMed ID: 177449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between the long-acting thyroid stimulator and the thyroid microsomal antibody.
    Bonnyns M; Vanhaelst L
    J Endocrinol; 1969 Jan; 43(1):125-6. PubMed ID: 4886576
    [No Abstract]   [Full Text] [Related]  

  • 6. Concentration of long-acting thyroid stimulator (LATS) by subfractionation of gamma G globulin from Graves' disease serum.
    Miyai K; Werner SC
    J Clin Endocrinol Metab; 1966 May; 26(5):504-12. PubMed ID: 5952570
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of antithyroid therapy on the long-acting thyroid stimulator and the antithyroglobulin antibodies.
    Pinchera A; Liberti P; Martino E; Fenzi GF; Grasso L; Rovis L; Baschieri L; Doria G
    J Clin Endocrinol Metab; 1969 Feb; 29(2):231-8. PubMed ID: 4179303
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies on a receptor assay for an antibody to human thyroid plasma membrane.
    Ochi Y; Hosoda S; Hachiya T; Yoshimura M; Miyazaki T; Kajita Y
    Acta Endocrinol (Copenh); 1979 May; 91(1):89-98. PubMed ID: 582221
    [No Abstract]   [Full Text] [Related]  

  • 9. [Long-acting thyroid stimulator (LATS) in thyroid gland diseases and its relationship to the thyroid gland antibodies].
    Weissbecker L; Uthgenannt H; Schemmel K; Müller W; Heesen H; Eickenbusch W; Bindeballe W
    Schweiz Med Wochenschr; 1967 Jul; 97(28):898-904. PubMed ID: 5587446
    [No Abstract]   [Full Text] [Related]  

  • 10. Autoimmune thyroid disease: an integrated concept of Graves' and Hashimoto's diseases.
    Selenkow HA; Wyman P; Allweiss P
    Compr Ther; 1984 Apr; 10(4):48-56. PubMed ID: 6373115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of radioablation of the thyroid gland in Graves' disease with high levels of long-acting thyroid stimulator (LATS).
    Volpé R; Desbarats-Schonbaum ML; Schonbaum E; Row VV; Ezrin C
    Am J Med; 1969 Feb; 46(2):217-26. PubMed ID: 5818477
    [No Abstract]   [Full Text] [Related]  

  • 12. Postpartum recurrence of hyperthyroidism and changes of thyroid-stimulating immunoglobulins in Graves' disease.
    Yabu Y; Amino N; Mori H; Miyai K; Tanizawa O; Takai SI; Kumahara Y; Matsuzuka F; Kuma K
    J Clin Endocrinol Metab; 1980 Dec; 51(6):1454-8. PubMed ID: 6108332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The role of hereditary and environmental factors in autoimmune thyroid diseases].
    Balázs C
    Orv Hetil; 2012 Jul; 153(26):1013-22. PubMed ID: 22735372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Human thyroid stimulator (HTS) in thyroid diseases].
    Hu ZY
    Zhonghua Nei Ke Za Zhi; 1984 Aug; 23(8):480-3, 525. PubMed ID: 6548953
    [No Abstract]   [Full Text] [Related]  

  • 15. Demonstration of circulating autoantibodies against the plasma membrane of isolated thyroid cells in Graves' disease.
    Hopf U; Fiek T; Grün R; Zuschneid W
    J Clin Lab Immunol; 1982 Oct; 9(1):49-53. PubMed ID: 6757440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The link between Graves' disease and Hashimoto's thyroiditis: a role for regulatory T cells.
    McLachlan SM; Nagayama Y; Pichurin PN; Mizutori Y; Chen CR; Misharin A; Aliesky HA; Rapoport B
    Endocrinology; 2007 Dec; 148(12):5724-33. PubMed ID: 17823263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [TSH-receptor-bound antithyroid antibody and the etiology of Basedow's disease].
    Shishiba Y
    Nihon Rinsho; 1983; 41(4):801-7. PubMed ID: 6310180
    [No Abstract]   [Full Text] [Related]  

  • 18. [Studies on the problem of a relationship between the occurrence of thyroid antibodies and LATS in hyperthyreosis].
    Weissbecker L; Uthgenannt H; Schemmel K; Müller W; Heesen H; Eickenbusch W; Bindeballe W
    Med Klin; 1966 Dec; 61(52):2062-3. PubMed ID: 5999210
    [No Abstract]   [Full Text] [Related]  

  • 19. The significance of antithyroglobulin and antithyroidal microsomal antibodies in patients with hyperthyroidism due to Graves' disease treated with antithyroidal drugs.
    Takaichi Y; Tamai H; Honda K; Nagai K; Kuma K; Nakagawa T
    J Clin Endocrinol Metab; 1989 Jun; 68(6):1097-100. PubMed ID: 2470772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Incidence of antithyroglobulin and antimicrosomal antibodies in thyroid pathology].
    Vallée G; Izembart M; Thonnet M
    Ann Biol Clin (Paris); 1982; 40(6):651-6. PubMed ID: 6897699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.